NCT03718611View on ClinicalTrials.gov

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 22, 2018

Primary Completion Date

March 18, 2019

Study Completion Date

May 17, 2019

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BR9001

BR9001 is a test drug as generic

DRUG

BR900A

BR900A is a reference drug

Trial Locations (1)

700-721

Kyungpook National University Hospital, Daegu

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY